Leisure Capital Management Astrazeneca PLC Transaction History

Leisure Capital Management

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2018 Nov 09, 2018	SELL	$34.76 - $39.72 $288,368 - $329,517	-8,296 Closed	0 $0
Q2 2018 Aug 02, 2018	BUY	$34.55 - $37.05 $22,595 - $24,230	654 Added 8.56%	8,296 $291,000
Q1 2018 May 11, 2018	SELL	$32.97 - $36.63 $4,187 - $4,652	-127 Reduced 1.63%	7,642 $267,000
Q4 2017 Feb 12, 2018	BUY	$32.09 - $34.78 $4,909 - $5,321	153 Added 2.01%	7,769 $270,000
Q3 2017 Oct 24, 2017	BUY	$28.96 - $34.0 $220,559 - $258,944	7,616	7,616 $258,000

1,350

477M

5.39M

3.75M

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $223B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

Get notified when there are updates to the investment portfolio of Leisure Capital Management, based on Form 13F filings with the SEC.

Stay updated on Leisure Capital Management with notifications on news.